Free and no obligation
References Wong ND, Karthikeyan H, Fan W
Outcome and FollowUp A followup testing 1 week postdiscontinuation revealed a notable improvement in liver enzymes (AST: 37 U/L, ALT: 78 U/L)
Many individuals begin experiencing reduced hunger, improved portion control, and fewer cravings as their body adjusts to the treatment
This medication works by mimicking the action of the naturally occurring GLP-1 hormone, enhancing glucose-dependent insulin secretion, suppressing inappropriate glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways
This mechanism reduces your appetite, eliminates food noise and cravings, and helps you easily sustain a calorie deficit